These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 28729939)

  • 41. Longitudinal Neuroimaging Hippocampal Markers for Diagnosing Alzheimer's Disease.
    Platero C; Lin L; Tobar MC
    Neuroinformatics; 2019 Jan; 17(1):43-61. PubMed ID: 29785624
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prediction of amyloid pathology in cognitively unimpaired individuals using voxel-wise analysis of longitudinal structural brain MRI.
    Petrone PM; Casamitjana A; Falcon C; Artigues M; Operto G; Cacciaglia R; Molinuevo JL; Vilaplana V; Gispert JD;
    Alzheimers Res Ther; 2019 Aug; 11(1):72. PubMed ID: 31421683
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Associations between hippocampal morphometry and neuropathologic markers of Alzheimer's disease using 7 T MRI.
    Blanken AE; Hurtz S; Zarow C; Biado K; Honarpisheh H; Somme J; Brook J; Tung S; Kraft E; Lo D; Ng DW; Vinters HV; Apostolova LG
    Neuroimage Clin; 2017; 15():56-61. PubMed ID: 28491492
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A novel joint HCPMMP method for automatically classifying Alzheimer's and different stage MCI patients.
    Sheng J; Wang B; Zhang Q; Liu Q; Ma Y; Liu W; Shao M; Chen B
    Behav Brain Res; 2019 Jun; 365():210-221. PubMed ID: 30836158
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Local MRI analysis approach in the diagnosis of early and prodromal Alzheimer's disease.
    Chincarini A; Bosco P; Calvini P; Gemme G; Esposito M; Olivieri C; Rei L; Squarcia S; Rodriguez G; Bellotti R; Cerello P; De Mitri I; Retico A; Nobili F;
    Neuroimage; 2011 Sep; 58(2):469-80. PubMed ID: 21718788
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combining viscoelasticity, diffusivity and volume of the hippocampus for the diagnosis of Alzheimer's disease based on magnetic resonance imaging.
    Gerischer LM; Fehlner A; Köbe T; Prehn K; Antonenko D; Grittner U; Braun J; Sack I; Flöel A
    Neuroimage Clin; 2018; 18():485-493. PubMed ID: 29527504
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Distinct dynamic profiles of microglial activation are associated with progression of Alzheimer's disease.
    Hamelin L; Lagarde J; Dorothée G; Potier MC; Corlier F; Kuhnast B; Caillé F; Dubois B; Fillon L; Chupin M; Bottlaender M; Sarazin M
    Brain; 2018 Jun; 141(6):1855-1870. PubMed ID: 29608645
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Random Forest ensembles for detection and prediction of Alzheimer's disease with a good between-cohort robustness.
    Lebedev AV; Westman E; Van Westen GJ; Kramberger MG; Lundervold A; Aarsland D; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Lovestone S; Simmons A;
    Neuroimage Clin; 2014; 6():115-25. PubMed ID: 25379423
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inexpensive, non-invasive biomarkers predict Alzheimer transition using machine learning analysis of the Alzheimer's Disease Neuroimaging (ADNI) database.
    Beltrán JF; Wahba BM; Hose N; Shasha D; Kline RP;
    PLoS One; 2020; 15(7):e0235663. PubMed ID: 32716914
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Standardization of hippocampus volumetry using automated brain structure volumetry tool for an initial Alzheimer's disease imaging biomarker.
    Abrigo J; Shi L; Luo Y; Chen Q; Chu WCW; Mok VCT;
    Acta Radiol; 2019 Jun; 60(6):769-776. PubMed ID: 30185071
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
    Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
    Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A fast approach for hippocampal segmentation from T1-MRI for predicting progression in Alzheimer's disease from elderly controls.
    Platero C; Tobar MC
    J Neurosci Methods; 2016 Sep; 270():61-75. PubMed ID: 27328371
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Performance of Hippocampus Volumetry with FSL-FIRST for Prediction of Alzheimer's Disease Dementia in at Risk Subjects with Amnestic Mild Cognitive Impairment.
    Suppa P; Hampel H; Kepp T; Lange C; Spies L; Fiebach JB; Dubois B; Buchert R;
    J Alzheimers Dis; 2016; 51(3):867-73. PubMed ID: 26923010
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of APOE Genotype on Hippocampal Atrophy over Time - An N=1925 Surface-Based ADNI Study.
    Li B; Shi J; Gutman BA; Baxter LC; Thompson PM; Caselli RJ; Wang Y;
    PLoS One; 2016; 11(4):e0152901. PubMed ID: 27065111
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of minimal thickness of the medial temporal lobe with hippocampal volume, maximal and minimal hippocampal length: volumetric approach with horizontal magnetic resonance imaging scans for evaluation of a diagnostic marker for neuroimaging of Alzheimer's disease.
    Uotani C; Sugimori K; Kobayashi K
    Psychiatry Clin Neurosci; 2006 Jun; 60(3):319-26. PubMed ID: 16732748
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Using path signatures to predict a diagnosis of Alzheimer's disease.
    Moore PJ; Lyons TJ; Gallacher J;
    PLoS One; 2019; 14(9):e0222212. PubMed ID: 31536538
    [TBL] [Abstract][Full Text] [Related]  

  • 57. One-year Follow-up Study of Hippocampal Subfield Atrophy in Alzheimer's Disease and Normal Aging.
    Madusanka N; Choi HK; So JH; Choi BK; Park HG
    Curr Med Imaging Rev; 2019; 15(7):699-709. PubMed ID: 32008518
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 3D-Deep Learning Based Automatic Diagnosis of Alzheimer's Disease with Joint MMSE Prediction Using Resting-State fMRI.
    Duc NT; Ryu S; Qureshi MNI; Choi M; Lee KH; Lee B
    Neuroinformatics; 2020 Jan; 18(1):71-86. PubMed ID: 31093956
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A comparison of medial and lateral temporal lobe atrophy in dementia with Lewy bodies and Alzheimer's disease: magnetic resonance imaging volumetric study.
    Barber R; McKeith IG; Ballard C; Gholkar A; O'Brien JT
    Dement Geriatr Cogn Disord; 2001; 12(3):198-205. PubMed ID: 11244213
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of automated volumetry of the hippocampus using NeuroQuant® and visual assessment of the medial temporal lobe in Alzheimer's disease.
    Persson K; Barca ML; Cavallin L; Brækhus A; Knapskog AB; Selbæk G; Engedal K
    Acta Radiol; 2018 Aug; 59(8):997-1001. PubMed ID: 29172642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.